Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.

Prince JB

首页> 外文期刊>Child and adolescent psychiatric clinics of North America >Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.

【24h】

Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.

机译：儿童和青少年注意缺陷多动障碍的药物治疗：新的兴奋剂制剂，阿托西汀和新颖疗法的最新进展。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This article reviews data on the safety, tolerability, and efficacy of the extended-delivery stimulant preparations and atomoxetine, including nine methylphenidate formulations, five amphetamine formulations, and one norepinephrine reuptake inhibitor, now indicated for treatment of attention-deficit hyperactivity disorder (ADHD). Six of the nine methylphenidate formulations, three of the five compounds, and the norepinephrine reuptake inhibitor are long-acting, potentially once-daily agents. Data on treatment of common adverse events are described, and data on investigational treatments of ADHD are reviewed.

机译：本文回顾了延长递送兴奋剂制剂和托莫西汀的安全性，耐受性和功效数据，包括九种哌醋甲酯制剂，五种苯丙胺制剂和一种去甲肾上腺素再摄取抑制剂，这些药物现已用于治疗注意力缺陷多动障碍（ADHD）。九种哌醋甲酯制剂中的六种，五种化合物中的三种以及去甲肾上腺素再摄取抑制剂是长效药物，可能每天一次。描述了常见不良事件的治疗数据，并综述了多动症的研究治疗数据。

著录项

来源
《Child and adolescent psychiatric clinics of North America》 |2006年第1期|共38页
作者
Prince JB;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; 轻微脑损伤综合征; 中枢神经系统刺激剂; 儿童; 迟效制剂; 哌醋甲酯; 去甲肾上腺素;

机译：Adolescent;Attention Deficit Disorder with Hyperactivity;Central Nervous System Stimulants;轻微脑损伤综合征;中枢神经系统刺激剂;儿童;迟效制剂;哌醋甲酯;去甲肾上腺素;

相似文献

外文文献
中文文献
专利

1. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. [J] . Prince JB Child and adolescent psychiatric clinics of North America . 2006,第1期

机译：儿童和青少年注意缺陷多动障碍的药物治疗：新的兴奋剂制剂，阿托西汀和新颖疗法的最新进展。
2. Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine, Stimulants, and No Pharmacotherapy [J] . Schneider Gary, Banaschewski Tobias, Feldman Brian L., Journal of child and adolescent psychopharmacology . 2019,第4期

机译：儿童和青少年的体重和高度具有关注缺陷/多动障碍：纵向数据库研究评估舌芬，兴奋剂和药物治疗的影响
3. Atomoxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Systematic Review of Review Papers 2009–2011. An Update for Clinicians [J] . Chris J. Bushe MBBS, Nicola Savill Journal of Central Nervous System Disease . 2011,第3期

机译：在儿童和青少年中的奥昔昔汀，具有注意力缺陷/多动障碍。 2009 - 2011年审查报纸系统审查。临床医生的更新
4. (945)DETECTION OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADOLESCENTS IN THE REGION OF “LA MANCHUELA” (ALBACETE- CUENCA) [C] . MJ. Pascual, J. Torres Pujol, J. Martinez-Raga International Technology,Education and Development Conference . 2011

机译：（945）在“La Manchuela”区域（Albacete-昆卡）的青少年中的注意力缺陷多动障碍检测
5. Sensory Processing within Attention-Deficit/Hyperactivity Disorder in Children and Adolescents [D] . Odeh, Sophia . 2020

机译：儿童和青少年注意力缺陷/多动障碍中的感官处理
6. Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine Stimulants and No Pharmacotherapy [O] . Gary Schneider, Tobias Banaschewski, Brian L. Feldman, -1

机译：注意缺陷/多动症的儿童和青少年的体重和身高：纵向数据库研究评估胍法辛兴奋剂和无药物治疗的影响
7. DU1 COMPARATIVE SAFETY OF STIMULANT AND ATOMOXETINE ASSOCIATED WITH THE RISK OF SUBSTANCE USE DISORDER AMONG ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER [O] . Bhattacharjee S., Chen H., Bhatara V., 2011

机译：注意力不集中/多动障碍青少年中兴奋剂和阿托莫西汀的相对安全性与物质使用障碍的风险

Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments.

摘要

著录项

相似文献

相关主题

期刊订阅